Vanguard Group’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $822M | Sell |
|
|||||
|
2025
Q1 | $588M | Sell |
|
|||||
|
2024
Q4 | $591M | Buy |
|
|||||
|
2024
Q3 | $618M | Buy |
|
|||||
|
2024
Q2 | $705M | Buy |
|
|||||
|
2024
Q1 | $599M | Buy |
|
|||||
|
2023
Q4 | $564M | Buy |
|
|||||
|
2023
Q3 | $300M | Buy |
|
|||||
|
2023
Q2 | $375M | Buy |
|
|||||
|
2023
Q1 | $264M | Buy |
|
|||||
|
2022
Q4 | $253M | Buy |
|
|||||
|
2022
Q3 | $373M | Buy |
|
|||||
|
2022
Q2 | $284M | Buy |
|
|||||
|
2022
Q1 | $353M | Sell |
|
|||||
|
2021
Q4 | $593M | Sell |
|
|||||
|
2021
Q3 | $574M | Buy |
|
|||||
|
2021
Q2 | $490M | Buy |
|
|||||
|
2021
Q1 | $536M | Buy |
|
|||||
|
2020
Q4 | $582M | Buy |
|
|||||
|
2020
Q3 | $444M | Sell |
|
|||||
|
2020
Q2 | $384M | Buy |
|
|||||
|
2020
Q1 | $285M | Buy |
|
|||||
|
2019
Q4 | $350M | Buy |
|
|||||
|
2019
Q3 | $319M | Buy |
|
|||||
|
2019
Q2 | $404M | Buy |
|
|||||
|
2019
Q1 | $317M | Buy |
|
|||||
|
2018
Q4 | $206M | Buy |
|
|||||
|
2018
Q3 | $292M | Buy |
|
|||||
|
2018
Q2 | $230M | Buy |
|
|||||
|
2018
Q1 | $310M | Buy |
|
|||||
|
2017
Q4 | $250M | Buy |
|
|||||
|
2017
Q3 | $135M | Buy |
|
|||||
|
2017
Q2 | $71.7M | Buy |
|
|||||
|
2017
Q1 | $48.8M | Buy |
|
|||||
|
2016
Q4 | $25.4M | Buy |
|
|||||
|
2016
Q3 | $21.2M | Buy |
|
|||||
|
2016
Q2 | $11.5M | Buy |
|
|||||
|
2016
Q1 | $9.53M | Buy |
|
|||||
|
2015
Q4 | $13.3M | Buy |
|
|||||
|
2015
Q3 | $4.6M | Buy |
|
|||||
|
2015
Q2 | $4.9M | Buy |
|